Dermal exposure to cyclophosphamide in hospitals during preparation, nursing and cleaning activities

International Archives of Occupational and Environmental Health

Volumn 78, Issue 5, 2005, Pages 403-412

  Fransman, Wouter ^a   Vermeulen, Roel ^a,b   Kromhout, Hans ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Anti neoplastic drugs; Cyclophosphamide; Dermal exposure; Hospital; Nurses; Pharmacy technicians

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; LATEX; NITRILE;

AIR POLLUTION; ARTICLE; DAILY LIFE ACTIVITY; DRUG EXPOSURE; FOREARM; FOREHEAD; HAND WASHING; HOSPITAL EQUIPMENT; HOSPITAL PERSONNEL; HUMAN; JOB PERFORMANCE; MAJOR CLINICAL STUDY; NURSE PRACTITIONER; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HAZARD; OCCUPATIONAL TOXICOLOGY; PATIENT CARE; PHARMACIST; PROTECTIVE CLOTHING; RISK ASSESSMENT; SKIN;

ANTINEOPLASTIC AGENTS, ALKYLATING; CYCLOPHOSPHAMIDE; HUMANS; OCCUPATIONAL EXPOSURE; ONCOLOGY SERVICE, HOSPITAL; PERSONNEL, HOSPITAL; SKIN ABSORPTION;

GOSSYPIUM HIRSUTUM;

EID: 21244481281     PISSN: 03400131     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00420-004-0595-1     Document Type: Article

References (23)

1. Brouwer DH, Boeniger MF, van Hemmen JJ (2000) Hand wash and manual skin wipes. Ann Occup Hyg 44:501-510 10.1016/S0003-4878(00)00036-3
2. Connor TH, Anderson RW, Sessink PJM, Broadfield L, Power LA (1999) Surface contamination with antineoplastic agents in six cancer treatment centers in Canada and the United States. Am J Health Syst Pharm 56:1427-1432 1:STN:280:DyaK1MzlsFCjtg%3D%3D
3. Fransman W, Vermeulen R, Kromhout H (2004) Occupational dermal exposure to cyclophosphamide in Dutch hospitals: A pilot study. Ann Occup Hyg 48:237-244 10.1093/annhyg/meh017
4. Goloni-Bertollo EM, Tajara EH, Manzato AJ, Varella-Garcia M (1992) Sister chromatid exchanges and chromosome aberrations in lymphocytes of nurses handling antineoplastic drugs. Int J Cancer 50:341-344 1:STN:280:By2C3sfgs1A%3D
5. Hornung RW, Reed LD (1990) Estimation of average concentration in the presence of nondetectable values. Appl Occup Environ Hyg 5:46-51 1:CAS:528:DyaK3cXltVyitr4%3D
6. Kromhout H, Hoek F, Uitterhoeve R, Huijbers R, Overmars RF, Anzion R, Vermeulen R (2000) Postulating a dermal pathway for exposure to anti-neoplastic drugs among hospital workers. Applying a conceptual model to the results of three workplace surveys. Ann Occup Hyg 44:551-560 10.1016/S0003-4878(00)00050-8
7. Mason HJ, Morton J, Garfitt SJ, Iqbal S, Jones K (2003) Cytotoxic drug contamination on the outside of vials delivered to a hospital pharmacy. Ann Occup Hyg 47:681-685 10.1093/annhyg/meg078
8. McDevitt JJ, Lees PS, McDiarmid MA (1993) Exposure of hospital pharmacists and nurses to antineoplastic agents. J Occup Med 35:57-60 1:STN:280:ByyC3sbovFc%3D
9. Milkovic-Kraus S, Horvat D (1991) Chromosomal abnormalities among nurses occupationally exposed to antineoplastic drugs. Am J Ind Med 19:771-774 1:STN:280:By6A2MzlvFI%3D
10. Minoia C, Turci R, Sottani C, Schiavi A, Perbellini L, Angeleri S, Draicchio F, Apostoli P (1998) Application of high performance liquid chromatography/tandem mass spectrometry in the environmental and biological monitoring of health care personnel occupationally exposed to cyclophosphamide and ifosfamide. Rapid Commun Mass Spectrom 12:1485-1493 10.1002/(SICI)1097-0231(19981030)12:20<1485::AID-RCM333>3.3.CO;2-E
11. Pohlová H, Cernà M, Rössner P (1986) Chromosomal aberrations, SCE and urine mutagenicity in workers occupationally exposed to cytostatic drugs. Mutat Res 174:213-217 10.1016/ 0165-7992(86)90154-5
12. Sardas S, Gök S, Karakaya AE (1991) Sister chromatid exchanges in lymphocytes of nurses handling antineoplastic drugs. Toxicol Lett 55:311-315 10.1016/0378-4274(91)90012-U
13. Selevan SG, Lindbohm ML, Hornung RW, Hemminki K (1985) A study of occupational exposure to antineoplastic drugs and fetal loss in nurses. N Engl J Med 313:1173-1178 1:STN:280:BimD2c%2FitFY%3D
14. Sessink PJM, Anzion RBM, van den Broek PHH, Bos RP (1992a) Detection of contamination with anti-neoplastic agents in a hospital pharmacy department. Pharmaceutisch Weekblad 14:16-22 1:STN:280:By2B3cvmslY%3D
15. Sessink PJM, Boer KA, Scheefhals APH, Anzion RBM, Bos RP (1992b) Occupational exposure to antineoplastic agents at several departments in a hospital. Int Arch Occup Environ Health 64:105-112 10.1007/BF00381477
16. Sessink PJM, Scholtes MM, Anzion RBM, Bos RP (1993) Determination of cyclofosfamide in urine by gas chromatography-mass spectrometry. J Chromatogr B Biomed Appl 616:333-337 10.1016/0378-4347(93)80404-R
17. Sessink PJ, Cerna M, Rossner P, Pastorkova A, Bavarova H, Frankova K, Anzion RB, Bos RP (1994a) Urinary cyclophosphamide excretion and chromosomal aberrations in peripheral blood lymphocytes after occupational exposure to antineoplastic agents. Mutat Res 309:193-199 1:CAS:528:DyaK2cXls12qurY%3D
18. Sessink PJ, van de Kerkhof MC, Anzion RB, Noordhoek J, Bos RP (1994b) Environmental contamination and assessment of exposure to antineoplastic agents by determination of cyclophosphamide in urine of exposed pharmacy technicians: Is skin absorption an important exposure route? Arch Environ Health 49:165-169 1:STN:280:ByuB2c7nvVQ%3D
19. Sessink PJ, Kroese ED, van Kranen HJ, Bos RP (1995) Cancer risk assessment for health care workers occupationally exposed to cyclophosphamide. Int Arch Occup Environ Health 67:317-323 10.1007/ BF00385647
20. Sessink PJ, Wittenhorst BC, Anzion RB, Bos RP (1997) Exposure of pharmacy technicians to antineoplastic agents: Reevaluation after additional protective measures. Arch Environ Health 52:240-244 1:CAS:528:DyaK2sXjvVyhtrw%3D
21. van Strien RT, Verhoeff AP, Brunekreef B, Van Wijnen JH (1994) Mite antigen in house dust: Relationship with different housing characteristics in The Netherlands. Clin Exp Allergy 24:843-853 7812886
22. Stücker I, Caillard JF, Collin R, Gout M, Poyen D, Hemon D (1990) Risk of spontaneous abortion among nurses handling antineoplastic drugs. Scand J Work Environ Health 16:102-107 2353192
23. Waksvik H, Klepp O, Brogger A (1981) Chromosome analyses of nurses handling cytostatic agents. Cancer Treat Rep 65:607-610 1:STN:280:Bi6B3svjslY%3D